Timken director granted 2,270 deferred shares
Timken director Elizabeth Ann Harrell reported an acquisition of 2,270 shares of common stock as a compensation grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Timken director Elizabeth Ann Harrell reported an acquisition of 2,270 shares of common stock as a compensation grant. The footnotes explain this represents the vesting of 100% of time-based restricted share units granted on May 2, 2025, with no purchase price. Harrell elected to defer receipt of these shares under Timken’s deferred compensation plan for directors, so delivery will occur at a later date. After this award and including 96 shares received through dividend investment in 2025, her directly reported holdings total 20,294 shares of Timken common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,270 | $0.00 | $0.00 |
Footnotes (3)
- F1. Represents vesting of 100% of the time-based restricted share units granted on May 2, 2025.
- F2. The reporting person has elected to defer the receipt of such shares until a later date under the issuer's deferred compensation plan for directors.
- F3. Includes 96 shares received through dividend investment in 2025.
Key Figures
Key Terms
deferred compensation plan financial
dividend investment financial
grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Timken (TKR) director Elizabeth Ann Harrell report?
AI-generated analysis. How Rhea-AI works. Not financial advice.